RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Alliance Pharma Stock

Alliance Pharma ROA 2024

Alliance Pharma ROA

-0.08

Ticker

APH.L

ISIN

GB0031030819

WKN

913253

In 2024, Alliance Pharma's return on assets (ROA) was -0.08, a 91.73% increase from the -0.04 ROA in the previous year.

Alliance Pharma Aktienanalyse

What does Alliance Pharma do?

Alliance Pharma PLC is a globally operating pharmaceutical company specializing in the marketing and development of pharmaceutical products. The company is headquartered in the United Kingdom and was founded in 1996. Alliance Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Alliance Pharma's Return on Assets (ROA)

Alliance Pharma's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Alliance Pharma's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Alliance Pharma's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Alliance Pharma’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Alliance Pharma stock

What is the Return on Assets (ROA) of Alliance Pharma this year?

The Return on Assets (ROA) of Alliance Pharma is -0.08 undefined this year.

What was the ROA of Alliance Pharma compared to the previous year?

The ROA of Alliance Pharma has increased by 91.73% compared to the previous year.

What consequences do high ROA have for investors of Alliance Pharma?

A high ROA is advantageous for investors of Alliance Pharma, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Alliance Pharma?

A low ROA can be unfavorable for investors of Alliance Pharma as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Alliance Pharma affect the company?

An increase in ROA of Alliance Pharma can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Alliance Pharma impact the company?

A reduction in the ROA of Alliance Pharma can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Alliance Pharma?

Some factors that can influence the ROA of Alliance Pharma include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Alliance Pharma important for investors?

The ROA of Alliance Pharma is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Alliance Pharma take to improve ROA?

To improve ROA, Alliance Pharma can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Alliance Pharma pay?

Over the past 12 months, Alliance Pharma paid a dividend of 0.02 GBP . This corresponds to a dividend yield of about 5.54 %. For the coming 12 months, Alliance Pharma is expected to pay a dividend of 0.02 GBP.

What is the dividend yield of Alliance Pharma?

The current dividend yield of Alliance Pharma is 5.54 %.

When does Alliance Pharma pay dividends?

Alliance Pharma pays a quarterly dividend. This is distributed in the months of January, July, January, July.

How secure is the dividend of Alliance Pharma?

Alliance Pharma paid dividends every year for the past 0 years.

What is the dividend of Alliance Pharma?

For the upcoming 12 months, dividends amounting to 0.02 GBP are expected. This corresponds to a dividend yield of 5.59 %.

In which sector is Alliance Pharma located?

Alliance Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Alliance Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Alliance Pharma from 7/18/2023 amounting to 0.012 GBP, you needed to have the stock in your portfolio before the ex-date on 6/22/2023.

When did Alliance Pharma pay the last dividend?

The last dividend was paid out on 7/18/2023.

What was the dividend of Alliance Pharma in the year 2023?

In the year 2023, Alliance Pharma distributed 0.017 GBP as dividends.

In which currency does Alliance Pharma pay out the dividend?

The dividends of Alliance Pharma are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Alliance Pharma stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Alliance Pharma

Our stock analysis for Alliance Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alliance Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.